Logo image
Giant Cell Myocarditis Presenting With Cardiogenic Shock: Diagnostic and Therapeutic Challenges
Journal article   Open access   Peer reviewed

Giant Cell Myocarditis Presenting With Cardiogenic Shock: Diagnostic and Therapeutic Challenges

Stefano H. Byer, Ibrahim Mortada, Mohammed Mhanna, Madalyn E. Walsh, Michael Arustamyan, Pavida Pachariyanon, Kathryn Eschbacher and Shareef Mansour
JACC. Case reports, Vol.30(17), 103859
07/02/2025
DOI: 10.1016/j.jaccas.2025.103859
PMCID: PMC12441243
PMID: 40615209
url
https://doi.org/10.1016/j.jaccas.2025.103859View
Published (Version of record) Open Access

Abstract

Giant cell myocarditis (GCM) is a rare but often fatal inflammatory cardiomyopathy characterized by aggressive myocardial inflammation and necrosis. Prompt recognition and immunosuppressive therapy are critical for improving outcomes. A 48-year-old woman with no prior cardiac history presented with dyspnea, orthopnea, and hypotension. Electrocardiography showed wide complex tachycardia with retrograde V-to-A conduction. Laboratory findings revealed rising high-sensitivity troponin, hepatic injury, and leukocytosis. Echocardiography showed biventricular failure, and cardiac magnetic resonance imaging showed myocardial edema and subepicardial enhancement. Endomyocardial biopsy confirmed GCM. Immunosuppressive therapy with corticosteroids, tacrolimus, and mycophenolate mofetil led to clinical improvement, avoiding transplantation. GCM remains a diagnostic and therapeutic challenge due to its rapid progression and arrhythmic burden. This case highlights the importance of early biopsy, tailored immunosuppression, and vigilant monitoring in managing fulminant myocarditis.
Immunosuppression endomyocardial biopsy giant cell myocarditis

Details

Metrics

8 Record Views
Logo image